FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Golden State Medical Supply GSMS Incorporated Recall

GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only,…

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Jun 17, 2026
Recall ID
D-0587-2026
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled GSMS Incorporated starting May 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0587-2026 on Jun 17, 2026. Reason: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

Product description

GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.

Lot numbers, UPCs & expiration codes

Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.

Where it was sold

Within the U.S Market.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0587-2026
Classification
Class II
Status
Ongoing
Recall initiated
May 29, 2026
FDA report date
Jun 17, 2026
Quantity
2,961 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-0587-2026, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Ongoing
Country
United States
Event ID
99127
Address
5187 Camino Ruiz
Code information
Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
Postal code
93012-8601
Report date
Jun 17, 2026
Product type
Drugs
Recall number
D-0587-2026
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
2,961 bottles
Reason for recall
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
Voluntary / mandated
Voluntary: Firm initiated
Product description
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
Distribution pattern
Within the U.S Market.
Recall initiation date
May 29, 2026
Initial firm notification
E-Mail
Center classification date
Jun 11, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0587-2026, published Jun 17, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls